Chemotherapy and Pharmacy Advisory Service of the National Institute for Health Research Looking for New Panel Members

The Chemotherapy and Pharmacy Advisory Service (CPAS) are currently seeking new panel members. The CPAS panel review draft and near final protocols to support investigators and each panel member will be asked to review up to SIX protocols per year. Though unpaid, membership and reviewing of protocols provides a significant training and development opportunity.

The CPAS welcome applications from clinicians, nurses, pharmacists and senior pharmacy technicians who work within a chemotherapy/radiopharmacy/clinical trials environment. (Pharmacy aseptics experience would also be useful). 
If you are interested in this exciting opportunity please submit your CV and short covering letter of application by email to: Mrs Sally Harvey, Pharmacy Advisor, Chemotherapy and Pharmacy Advisory Service, [email protected]

Latest News

By BOPA Research Committee on 25th April 2024

Survey: Pharmacogenomic Panel Testing in Cancer: UK Oncology Professionals

Please consider completing our BOPA member survey on the use of pharmacogenomic panel testing in people with solid tumours. Survey information I’m a pharmacist and pre-doctoral research fellow researching the…

Read article
By BOPA Research committee on 25th April 2024

NIHR Associate Principal Investigator (PI) Scheme is continuing to host Research Learning Lectures

The NIHR Associate Principal Investigator (PI) Scheme is continuing to host the Research Learning Lectures; a series of lectures for anyone in Health and Social Care interested in learning more about research.…

Read article
By BOPA on 16th April 2024

Abstract Submission for #BOPA2024 is NOW OPEN

Abstract Submission for the 27th Annual BOPA Conference in 2024 is now OPEN   Delegates are invited to present results of their clinical and technical work as a poster with…

Read article
By BOPA Research Subcommittee on 15th April 2024

Survey: Service Evaluation on Carboplatin Variation in UK

We invite members to complete this service evaluation to understand national variations in carboplatin dosing for adult patients receiving SACTs. We are looking at whether we can standardise carboplatin protocols…

Read article